Tue, November 8, 2022
Mon, November 7, 2022
Fri, November 4, 2022

Ed Arce Maintained (AKRO) at Strong Buy with Increased Target to $64 on, Nov 7th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-64-on-nov-7th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Ed Arce of HC Wainwright & Co., Maintained "Akero Therapeutics, Inc." (AKRO) at Strong Buy with Increased Target from $62 to $64 on, Nov 7th, 2022.

Ed has made no other calls on AKRO in the last 4 months.



There is 1 other peer that has a rating on AKRO. Out of the 1 peers that are also analyzing AKRO, 0 agree with Ed's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ed


  • Liisa Bayko of "Evercore ISI Group" Upgraded from Hold to Buy and Increased Target to $50 on, Wednesday, September 14th, 2022

Publication Contributing Sources